New funding awards - April 2017

Monday, May 8, 2017

Sponsored Research

Paul B. Rosenberg of Cardiology has received an award (1R01-DK109911-01A1) from the National Institutes of Health for a project entitled "STIM1 and mitochondrial quality control." Total funding will be $2,878,530.

Gillian D. Schmidler of Cardiology has received an award from the Agency for Healthcare Research and Quality for a project entitled "EPC V Task Order 38." Total funding will be $215,000.

Anna Mae Diehl of Gastroenterology has received an award from the Fibrolamellar Cancer Foundation for a project entitled "Role of the Stroma in Fibrolamellar Hepatocellular Carcinoma." Total funding will be $125,000.

Leigh Boulware of General Internal Medicine has received a sub-award (3UL1-TR001111-04S1) through the University of North Carolina - Chapel Hill for a project entitled "Regulatory Guidance for Academic Research of Drugs and Devices." Total funding will be $18,301.

Rowena J. Dolor of General Internal Medicine has received a sub-award (1R01-HS024943-01) through the University of Colorado - Denver for a project entitled "Why is use of the Medicare Intensive Behavioral Therapy for Obesity Benefit so low? Finding what works to promote wider dissemination." Total funding will be $62,326.

John Strouse of Hematology has received a sub-award (5U1-EMC27864-03-00) through Johns Hopkins University for a project entitled "Sickle Cell Treatment Demonstration." Total funding will be $48,105.

Rahima Zennadi of Hematology has received an award from the Vifor Fresenius Medical Care Renal Pharma for a project entitled "Testing The Effect Of Ferroportin Inhibitor On Sickle Cell Pathophysiology." Total funding will be $390,272.

Andrew Alspaugh of Infectious Diseases has received a sub-award (1R01-GM121458-01) through the University of Iowa for a project entitled "Mining the Coprophilous Mycobiome for new Cryptococcus Antiinfectives and Antifungal Synergists." Total funding will be $80,543.

Benjamin Anderson of Infectious Diseases has received an award through East Carolina University for a project entitled "Establishing Environmental Bioaerosol Surveillance in North Carolina Swine Farms." Total funding will be $5,000.

Manuela Carugati of Infectious Diseases has received an award through the University of Otago, New Zealand for a project entitled "Estimating the burden of invasive Salmonella infections in Tanzania." Total funding will be $27,000.

Mehri McKellar of Infectious Diseases has received a sub-award through the NC DHHS for a project entitled "Healthy Relationships: Region Seven Prevention for Positives." Total funding will be $25,000.

Nathan M. Thielman of Infectious Diseases has received an award (3T32-AI007392-27W1) from the National Institutes of Health for a project entitled "Interdisciplinary Research Training Program in AIDS." Total funding will be $8,644.

Nicholas Devito (Mentor: Brent A. Hanks) of Medical Oncology has received an award from the Conquer Cancer Foundation for a project entitled "Investigating Oncogenic Signaling Pathways that Drive Wnt Ligand-mediated Immune Tolerance in Melanoma." Total funding will be $50,000.

Patrick H. Pun of Nephrology has received an award (1R03-DK113324-01) from the National Institutes of Health for a project entitled "Evaluating and Improving Cardiac Arrest Resuscitation Efforts in Hemodialysis Clinics." Total funding will be $159,000.

Myles Wolf of Nephrology has received a sub-award through Northwestern University for a project entitled "Phosphate and FGF23: Dietary and Molecular Mediators of Health Disparities in Cardiovasular and Kidney Diseases (Center)." Total funding will be $25,535.

Myles Wolf of Nephrology has received an award (7R01-DK081374-11) from the National Institutes of Health for a project entitled "FGF23 and Cardiovascular Disease in CKD (CRIC)." Total funding will be $384,752.

Myles Wolf of Nephrology has received a sub-award (4R01-DK094796-05) through the University of Colorado - Denver for a project entitled "FGF-23 and Clinical outcomes in ADPKD." Total funding will be $160,000.

Alice L. Gray of Pulmonary, Allergy, and Critical Care Medicine has received an award from the Cystic Fibrosis Foundation for a project entitled "Award for a Mental Health Coordinator." Total funding will be $52,109.

Jamie L. Todd of Pulmonary, Allergy, and Critical Care Medicine has received a sub-award (5U01-AI063594-13) through the Mount Sinai School of Medicine for a project entitled "Hyaluronan in Acute Rejection and Chronic Lung Allograft Dysfunction after Human Lung Transplantation." Total funding will be $320,105.

Teresa Tarrant of Rheumatology and Immunology has received an award from the Rheumatology Research Foundation for a project entitled "Light-mediated delivery of therapeutics for Rheumatoid Arthritis." Total funding will be $300,000.

Donghai Wang of Rheumatology and Immunology has received an award (1R21-NS102628-01) from the National Institutes of Health for a project entitled "Innate Immune Inhibition of the Mevalonate Pathway impairs Neurodevelopment during ZIKA infection." Total funding will be $437,250.

Industry-sponsored Clinical Trials

Gerald S. Bloomfield of Cardiology has received an award from the General Electric Company for a project entitled "GE Stress AFI." Total funding will be $140,688.

Han W. Kim of Cardiology has received an award from Astellas Pharma Global Development, Inc for a project entitled "Myocardial Flow Reserve." Total funding will be $305,298.

Renato D. Lopes of Cardiology has received an award from GlaxoSmithKline for a project entitled "GSK-CKD Program CEC." Total funding will be $817,684.

Tracy Y. Wang of Cardiology has received an award from the AstraZeneca Healthcare Foundation for a project entitled "AZ CLiPPeR: Medication Changes Early after a Myocardial Infarction: Can Patients be Discharged with a 90-day Prescription." Total funding will be $40,000.

Manal F. Abdelmalek of Gastroenterology has received an award from Gilead Sciences, Inc. for a project entitled "A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Selonsertib in Subjects with Compensated Cirrhosis due to Nonalcoholic Steatohepatitis (NASH)." Total funding will be $864,076.

Manal F. Abdelmalek of Gastroenterology has received an award from Gilead Sciences, Inc. for a project entitled "A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Selonsertib in Subjects with Nonalcoholic Steatohepatitis (NASH) and Bridging (F3) Fibrosis." Total funding will be $512,814.

Hayden B. Bosworth of General Internal Medicine has received an award from Improved Patient Outcomes, Inc. for a project entitled "Xarelto Afib." Total funding will be $192,518.

Bradley G. Hammill of General Internal Medicine has received an award from St. Jude Medical Inc. for a project entitled "Linking Medicare Claims and the SJM Patient Database." Total funding will be $175,000.

Ara D. Metjian of Hematology has received an award from Octapharma AG for a project entitled "An open-label, multicenter, Post-Marketing Requirement study to investigate the safety and tolerability of octaplas in the management of pediatric patients who require therapeutic plasma exchange." Total funding will be $31,749.

Marilyn J. Telen of Hematology has received an award from BioMedomics, Inc. for a project entitled "Multi-site Clinical Laboratory Testing for SickleScan." Total funding will be $124,507.

Barbara D. Alexander of Infectious Diseases has received an award from the Astellas Pharma Global Development, Inc for a project entitled "Non-Interventional Registry Study of Systemic Antifungal Therapy in Adult Subjects with Invasive Mucormycosis or Invasive Aspergillosis Caused by a Non-fumigatus Species (PMC Registry)." Total funding will be $264,597.

Barbara D. Alexander of Infectious Diseases has received an award from the Astellas Pharma Global Development, Inc for a project entitled "Observational Disease Registry of Patients Treated with Systemic Mold-Active Triazoles (MAT Registry)." Total funding will be $307,672.

Gregory Gray of Infectious Diseases has received an award trough Vysnova Partners, Inc. for a project entitled "Southeast Asia (SEA) Biosurveillance and Epidemiology Research Support." Total funding will be $118,908.

Rachel Miller of Infectious Diseases has received an award from Scynexis Inc for a project entitled "Scynexis - Scy-078 301." Total funding will be $67,398.

Jeffrey M. Clarke of Medical Oncology has received an award from Bayer HealthCare AG for a project entitled "An open-label Phase I dose-escalation study." Total funding will be $253,630.

Brent A. Hanks of Medical Oncology has received an award from AstraZeneca Pharmaceuticals, LP for a project entitled "Targeting CXCR2-mediated Myeloid-derived Suppressor Cell Recruitment as a Strategy for Reversing Adaptive Resistance to Anti-PD-1 Antibody Immunotherapy." Total funding will be $31,800.

Michael A. Morse of Medical Oncology has received an award from Ipsen Biopharmaceuticals, Inc. for a project entitled "Phase Ib/II Study of Pembrolizumab with Lanreotide Depot for Gastroenteropancreatic Neuroendocrine Tumors (PLANET)." Total funding will be $678,995.

Neil R. MacIntyre of Pulmonary, Allergy, and Critical Care Medicine has received an award from Vyaire Medical, Inc. for a project entitled "Vyaire Educational Workshop." Total funding will be $17,250.

Lake D. Morrison of Pulmonary, Allergy, and Critical Care Medicine has received an award from the Boehringer Ingelheim Corporation for a project entitled "A 52-week, double blind, randomized, placebo-controlled trial evaluating the efficacy and safety of Nintedanib, 150 mg twice daily, in patients with Progressive Fibrosing Interstitial Lung Disease (PF-ILD)." Total funding will be $507,491.

Momen Wahidi of Pulmonary, Allergy, and Critical Care Medicine has received an award from Broncus Medical, Inc. for a project entitled "EAST 2: Elaluation of the Archimedes System for Transparenchymal Nodule Access 2." Total funding will be $130,226.

Ankoor Shah of Rheumatology and Immunology has received an award from Reata Pharmaceuticals, Inc. for a project entitled "An Extended Access Program to Assess Long-Term Safety of Bardoxolone Methyl in Patients with Pulmonary Hypertension." Total funding will be $55,924.